Viewing Study NCT02099292


Ignite Creation Date: 2025-12-24 @ 3:44 PM
Ignite Modification Date: 2026-02-20 @ 8:27 PM
Study NCT ID: NCT02099292
Status: COMPLETED
Last Update Posted: 2014-03-28
First Post: 2014-03-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Rituximab and DexaBEAM as Salvage Therapy for Relapsed Lymphoma
Sponsor: Georg Hess, MD
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed Non-Hodgkin-Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None lymphoma View
None high dose therapy View
None DexaBEAM View
None Rituximab View
None role of alternative salvage treatment - dexaBEAM View